This ticker has not been starred yet RGLS Regulus Therapeutics Inc.
Pharmaceutical Preparations
Book value per $ invested $ 3.55
Leverage 7.42%
Market Cap $ 24.5m
PE 0.00
Dividend Yield 0.00%
Profit $ -41.4m
Margin 0.00%

Regulus Therapeutics Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of drugs that target microRNAs to treat a variety of diseases in the United States. The company is headquartered in San Diego, California.

Subscribe Now For Access - Only $1.99 Per Month